相关实验视频
Updated: Jan 13, 2026

06:53
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
12.9K
在特定的皮肤祖先群体中,SOX2赋予了瘤的容许性
Patricia P Centeno1,2, Christopher Chester3,4, Georgios Kanellos5
1Cancer Research UK Scotland Institute, Glasgow, UK. P.Centeno@crukscotlandinstitute.ac.uk.
Nature communications
|January 8, 2026
概括
皮肤干细胞和原始细胞对导致皮肤状细胞癌 (cSCC) 的突变有不同的反应. 原始体中的SOX2过度表达,与MAPK激活,使得瘤迅速形成.
科学领域:
- 皮肤病学 皮肤病学
- 癌症生物学 癌症生物学
- 干细胞生物学 干细胞生物学
背景情况:
- 皮肤的更新取决于干细胞和原始细胞,但它们对皮肤状细胞癌 (cSCC) 致癌突变的不同易感性尚不清楚.
- 矛盾的是,BRAF抑制剂激活MAPK信号,导致黑色素瘤患者快速发展cSCC.
研究的目的:
- 调查表皮干细胞和原生细胞对驱动cSCC.cSCC的致癌突变的不同敏感性.
- 通过模拟矛盾的MAPK激活或MAPK过度激活的基因小鼠模型来模拟cSCC发育.
主要方法:
- 使用了两个小鼠模型:HRASG12V与BRAF抑制剂 (模仿矛盾的MAPK激活) 和BRAFV600E (MAPK过度激活).
- 向瘤基因突变发生在基底表皮的毛囊间干细胞和差异化承诺的原始细胞中.
- 分析了瘤形成,细胞反应和基因表达特征,包括SOX2.2.
主要成果:
- 外皮干细胞迅速形成瘤,而原始细胞表现出耐药性,尽管保留了突变.
- 这两个细胞群最终产生了类似的瘤,表明共享的转化过程.
- SOX2在原始瘤中具有独特的上调,并且存在于20%的人类cSCC中.
结论:
- 承诺的原始细胞对转化具有抵抗力,但可以使其对快速cSCC发展具有宽容性.
- SOX2上调,结合MAPK激活,可以诱导祖先的茎状状态,克服它们的抵抗力.
- SOX2可以作为从已被承诺的原生细胞中产生的cSCC的标记物.
相关概念视频
Pleiotropy
43.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.2K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K

